Aspectos neurológicos de la ceroidolipofuscinosis. - FEDAES
Aspectos neurológicos de la ceroidolipofuscinosis. - FEDAES
Aspectos neurológicos de la ceroidolipofuscinosis. - FEDAES
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
neuroimagen, los estudios neurofisiológicos y el examen ultraestructural.<br />
En <strong>la</strong>s etapas tempranas <strong>de</strong> <strong>la</strong> enfermedad, muchos pacientes<br />
exhiben hal<strong>la</strong>zgos <strong>neurológicos</strong> sutiles y resultan necesarias<br />
<strong>la</strong>s evaluaciones neurológica y oftalmológica <strong>de</strong>tal<strong>la</strong>das para<br />
1. Lyon G, Adams RD, Kolodny EH. Neurology of hereditary metabolic<br />
diseases in children. 2 ed. New York: McGrawHill; 1996.<br />
2. Aicardi J. Encefalopatías progresivas sin anomalía metabólica conocida.<br />
En Fejerman N, Fernán<strong>de</strong>z Álvarez E, eds. Neurología pediátrica.<br />
Buenos Aires: Panamericana; 1997. p. 38398.<br />
3. Mole SE. Recent advances in the molecu<strong>la</strong>r genetics of the neuronal<br />
ceroid lipofuscinoses. J Inherit Metab Dis 1996; 19: 26974.<br />
4. Boustany RM, Kolodny EH. The neuronal ceroid lipofuscinoses: a<br />
review. Rev Neurol (Paris) 1989; 145: 10510.<br />
5. Pego R, Amigo MC, Escriche D, Romero J, Navarro C. Biopsia muscu<strong>la</strong>r<br />
en <strong>la</strong> <strong>ceroidolipofuscinosis</strong>: estudio <strong>de</strong> tres casos <strong>de</strong> <strong>la</strong> forma<br />
juvenil. Rev Neurol 1995; 23: 62731.<br />
6. Idoate-Gastearena MA, Vega-Vázquez F. Diagnóstico <strong>de</strong> <strong>la</strong>s enfermeda<strong>de</strong>s<br />
neurometabólicas y neuro<strong>de</strong>generativas mediante biopsia cutánea.<br />
Rev Neurol 1997; 25 (Supl 3): S26980.<br />
7. Stengel OC. Account of a singu<strong>la</strong>r illness among four sibling in the<br />
vicinity of Roraas. Eyr (Chrristiania) 1826; 1: 34552.<br />
8. Batten F. Cerebral <strong>de</strong>generation with symmetrical changes in the macu<strong>la</strong>e<br />
in two members of a family. Trans Ophthalmol Soc (UK) 1903; 23: 38690.<br />
9. Dyken PR. The neuronal ceroid lipofuscinoses. J Child Neurol 1989;<br />
4: 16574.<br />
10. Bielschowsky M. Über Spatinfantile, familiäre amaurotische Idiotie<br />
mit kleinhim Symptomen. Dtsch Z Nervenheik 1913; 50: 729.<br />
11. Spielmeyer W. Klinische und anatomische Untersuchungen über eine<br />
beson<strong>de</strong>re Form von familiäre amaurotische Idiotie. Histol Histopathol<br />
1908; 2: 193215.<br />
12. Sjögren T. Die juvenile amaurotische Idiotie. Klinische und erblichkeitmedzinisch<br />
Untersuchungen. Hereditas 1931; 14: 197425.<br />
13. Kuf H. Über eine Spatform <strong>de</strong>r amaurotischen Idiotie und ihre heredofamiliaren<br />
Grund<strong>la</strong>gen. Zeitschrift für die Gesamte Neurologie und<br />
Psychiatrie 1925; 95; 16888.<br />
14. Santavuori P, Haltia M, Rapo<strong>la</strong> J, Raitta C. Infantile type of socalled<br />
neuronal ceroidlipofuscinoses. I. A clinical study of 15 patients. J<br />
Neurol Sci 1973; 18: 25767.<br />
15. Zeman W, Dyken P. Neuronal ceroidlipofuscinoses (Batten’s disease).<br />
Re<strong>la</strong>tionship to amaurotic familial idiocy? Pediatrics 1969; 44: 57083.<br />
16. Mole S. Neuronal ceroid lipofuscinoses. Eur J Paediatr Neurol 1997;<br />
5/6: 187.<br />
17. Boustany RM. Batten disease or neuronal ceroid lipofuscinoses. In<br />
Moser HW, ed. Handbook of clinical neurology: neurodystrophies and<br />
neurolipidoses. Amsterdam: Elsevier Science; 1996. p. 671700.<br />
18. Ri<strong>de</strong>r JA, Ri<strong>de</strong>r Dl. Batten disease: past, present, and future. Am J<br />
Med Genet 1988; (Suppl 5): 216.<br />
19. Boustany RM, Alroy J, Kolodny EH. Clinical c<strong>la</strong>ssification of neuronal<br />
ceroid lipofuscinoses subtypes. Am J Med Genet 1988; 5: 4758.<br />
20. Jarve<strong>la</strong> I, Schleutker J, Haataja I, et al. Infantile form of neuronal ceroid<br />
ASPECTOS NEUROLÓGICOS<br />
DE LA CEROIDOLIPOFUSCINOSIS<br />
Resumen. Objetivo. Comentar los <strong>de</strong>talles históricos, epi<strong>de</strong>miológicos,<br />
clínicos, exámenes complementarios y hal<strong>la</strong>zgos neuropatológicos<br />
<strong>de</strong> <strong>la</strong> <strong>ceroidolipofuscinosis</strong> en edad pediátrica. Desarrollo.<br />
Inicialmente, se revisan los conceptos básicos y <strong>de</strong>talles históricos<br />
re<strong>la</strong>cionados con el trastorno, y se discute <strong>la</strong> frecuencia y distribución<br />
<strong>de</strong> <strong>la</strong>s diversas formas clínicas. Más a<strong>de</strong><strong>la</strong>nte, se revisan los<br />
subtipos y variantes más frecuentes en edad pediátrica, con sus elementos<br />
<strong>de</strong> aproximación diagnóstica. Finalmente, se analizan los<br />
estudios neuropatológicos y su corre<strong>la</strong>ción clínica. Conclusiones. El<br />
diagnóstico clínico <strong>de</strong> <strong>ceroidolipofuscinosis</strong> <strong>de</strong>be sustentarse en una<br />
historia clínica que <strong>de</strong>muestre el compromiso visual, <strong>la</strong>s convulsiones<br />
y <strong>la</strong> regresión <strong>de</strong> <strong>la</strong>s funciones psicomotoras. Los hal<strong>la</strong>zgos <strong>de</strong><br />
neuroimagen, <strong>la</strong>s alteraciones neurofisiológicas y el estudio ultraestructural<br />
confirman el diagnóstico. [REV NEUROL 2000; 31: 283-7]<br />
[http://www.revneurol.com/3103/j030283.pdf]<br />
Pa<strong>la</strong>bras c<strong>la</strong>ve. Ceroidolipofuscinosis. Convulsiones. Degeneración<br />
macu<strong>la</strong>r. Enfermeda<strong>de</strong>s metabólicas. Ultraestructura.<br />
REV NEUROL 2000; 31 (3): 283-287<br />
BIBLIOGRAFÍA<br />
VIII CONGRESO ANUAL DE LA AINP<br />
confirmar <strong>la</strong> sospecha diagnóstica. Está pendiente <strong>la</strong> caracterización<br />
<strong>de</strong> los efectos bioquímicos y molecu<strong>la</strong>res <strong>de</strong> algunas variantes<br />
y esperamos que no esté muy lejana <strong>la</strong> posible intervención<br />
terapéutica <strong>de</strong> estos trastornos [34,35].<br />
lipofuscinoses (CLN1) map to the short arm of chromosome 1.<br />
Genomics 1991; 9: 1703.<br />
21. Vesa J, Hellsten E, Verkruyse LA, et al. Mutations in the palmitoyl<br />
protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis.<br />
Nature 1995; 376: 5848.<br />
22. Har<strong>de</strong>n A, Pampiglione G. Neurophysiological studies (EEG/ERG/<br />
VEP/SEP) in 88 children with socalled neuronal ceroid lipofuscinosis.<br />
In Armstrong D, Koppang N, Ri<strong>de</strong>r J, eds. Ceroid lipofuscinoses<br />
(Batten’s disease). Amsterdam: Elsevier; 1982. p. 6170.<br />
23. Autti T, Raininko R, Launes J, Nuuti<strong>la</strong> A, Santavuori P. Jansky-<br />
Bielschowsky variant disease: CT, MRI, and SPECT findings. Pediatr<br />
Neurol 1992; 8: 1216.<br />
24. Petersen B, Handwerker M, Huppertz HI. Neuroradiological findings<br />
in c<strong>la</strong>ssical <strong>la</strong>te infantile neuronal ceroid lipofuscinoses. Pediatr Neurol<br />
1996; 15: 3447.<br />
25. Seitz D, Grodd W, Schwab A, Seeger U, Klose U, Nagele T. MR<br />
imaging and localized proton MR spectroscopy in <strong>la</strong>te infantile neuronal<br />
ceroid lipofuscinosis. Am J Neuroradiol 1998; 19: 1373-7.<br />
26. Brockmann K, Pouwels PJ, Chisten HJ, Frahm J, Hanefeld F. Localized<br />
proton magnetic resonance spectroscopy of cerebral metabolic disturbances<br />
in children with neuronal ceroid lipofuscinosis. Neuropediatrics<br />
1996; 27: 52428.<br />
27. Boustany RM, Filipek P. Seizures, <strong>de</strong>pression and <strong>de</strong>mentia in teenagers<br />
with Batten disease. J Inher Metab Dis 1993; 16: 2525.<br />
28. Philippart M, Nessa C, Chugani HT. SpielmeyerVogt (Batten, Spielmeyer,<br />
Sjögren) disease. Distinctive patterns of cerebral glucose utilization.<br />
Brain 1994; 117: 108592.<br />
29. Braak H. Patterns of NCL lesions in the CNS and the problem of re<strong>la</strong>ted<br />
dysfunction. Clin Neuropathol 1992; 11: 157a.<br />
30. Chronister R, Dyken P, Fields PA, Maertens P. Cellu<strong>la</strong>r distribution of<br />
lesions in batten disease. Am J Med Genet 1995; 57: 1915.<br />
31. Walkley SU, March PA, Schroe<strong>de</strong>r CE, Wurzelmann S, Jolly RD.<br />
Pathogenesis of brain dysfunction in Batten disease. Am J Med Genet<br />
1995; 57: 196203.<br />
32. Lane S, Jolly RD, Schmechel DE, Alroy J, Boustany RM. Apoptosis<br />
as the mechanism of neuro<strong>de</strong>generation in Batten’s disease. J Neurochem<br />
1996; 67: 67783.<br />
33. Katz ML, Rodríguez M. Juvenile ceroidlipofuscinosis. Evi<strong>de</strong>nce for<br />
methy<strong>la</strong>ted lisien in neural storage body protein. Am J Pathol 1992;<br />
138: 32332.<br />
34. Mole S, Gardiner M. Molecu<strong>la</strong>r genetics of the neuronal ceroid lipofuscinoses.<br />
Epilepsia 1999; 40 (Suppl 3): 2932.<br />
35. Sleat DE, Gin RM, Sohar I, Wisniewski K, et al. Mutational analysis<br />
of the <strong>de</strong>fective protease in c<strong>la</strong>ssic <strong>la</strong>teinfantile neuronal ceroid lipofuscinoses,<br />
a neuro<strong>de</strong>generative lysosomal storage disor<strong>de</strong>r. Am J Hum<br />
Genet 1999; 64: 151123.<br />
ASPECTOS NEUROLÓGICOS<br />
DA CEROIDOLIPOFUSCINOSE<br />
Resumo. Objectivo. São comentados os <strong>de</strong>talhes históricos, epi<strong>de</strong>miológicos,<br />
clínicos, exames complementares e achados neuropatológicos<br />
da ceroidolipofuscinose na ida<strong>de</strong> pediátrica. Desenvolvimento.<br />
Inicialmente, são revistos os conceitos básicos e os <strong>de</strong>talhes históricos<br />
re<strong>la</strong>cionados com a doença e é discutida a frequência e distribuição<br />
das diversas formas clínicas. Mais adiante, são revistos os subtipos e<br />
variantes mais frequentes na ida<strong>de</strong> pediátrica, com os seus elementos<br />
<strong>de</strong> abordagem diagnóstica. Finalmente, são analisados os estudos<br />
neuropatológicos e a sua corre<strong>la</strong>ção clínica. Conclusões. O diagnóstico<br />
clínico <strong>de</strong> ceroidolipofuscinose <strong>de</strong>ve basear-se numa história clínica<br />
que <strong>de</strong>monstre o envolvimento visual, as convulsões e a regressão<br />
das funções psicomotoras. Os achados <strong>de</strong> neuroimagem, as alterações<br />
neurofisiológicas e o estudo ultra-estrutural confirmam o diagnóstico.<br />
[REV NEUROL 2000; 31: 283-7] [http://www.revneurol.com/<br />
3103/j030283.pdf]<br />
Pa<strong>la</strong>vras chave. Ceroidolipofuscinose. Convulsões. Degeneração<br />
macu<strong>la</strong>r. Doenças metabólicas. Ultra-estrutura.<br />
287